Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Fresenius Medical Care
FMS
$13B
| $174K | ﹤0.01% |
+3,600
| New | +$166K |
|
4427
Insulet
PODD
$9.91B
| $174K | ﹤0.01% |
3,401
+1,827
| +116% | +$79.3K |
|
|
MDC
4428
DELISTED
M.D.C. Holdings, Inc.
MDC
| $174K | ﹤0.01% |
6,219
+4,012
| +182% | +$105K |
|
4429
Donnelley Financial Solutions
DFIN
$1.17B
| $173K | ﹤0.01% |
7,517
-52,438
| -87% | -$1.15M |
|
4430
Knowles
KN
$3.27B
| $173K | ﹤0.01% |
10,198
-10,360
| -50% | -$186K |
|
4431
Seres Therapeutics
MCRB
$50.2M
| $173K | ﹤0.01% |
762
-985
| -56% | -$202K |
|
4432
PUT
Molina Healthcare
MOH
$10.4B
| $173K | ﹤0.01% |
2,500
-600
| -19% | -$36.8K |
|
4433
PUT
Equinor
EQNR
$97.4B
| $172K | ﹤0.01% |
10,400
+6,400
| +160% | +$110K |
|
4434
Omeros
OMER
$986M
| $172K | ﹤0.01% |
8,601
-1,004
| -10% | -$17.5K |
|
4435
Titan International
TWI
$457M
| $172K | ﹤0.01% |
14,288
-18,583
| -57% | -$200K |
|
|
CCEC
4436
Capital Clean Energy Carriers
CCEC
$1.34B
| $172K | ﹤0.01% |
7,223
-691
| -9% | -$16.5K |
|
|
AVHI
4437
DELISTED
A V Homes, Inc.
AVHI
| $172K | ﹤0.01% |
8,608
-9,397
| -52% | -$161K |
|
|
SPN
4438
PUT
DELISTED
Superior Energy Services, Inc.
SPN
| $172K | ﹤0.01% |
1,650
+590
| +56% | +$68.7K |
|
4439
PUT
Ally Financial
ALLY
$13.3B
| $171K | ﹤0.01% |
8,200
-9,900
| -55% | -$194K |
|
4440
PUT
Ashland
ASH
$3.45B
| $171K | ﹤0.01% |
2,600
-8,642
| -77% | -$550K |
|
4441
First Interstate BancSystem
FIBK
$3.56B
| $171K | ﹤0.01% |
4,582
-299
| -6% | -$11.2K |
|
4442
PUT
MBIA
MBI
$257M
| $171K | ﹤0.01% |
18,100
+3,300
| +22% | +$28.1K |
|
4443
CALL
ResMed
RMD
$31.9B
| $171K | ﹤0.01% |
2,200
+1,300
| +144% | +$93K |
|
4444
PUT
Rockwell Medical
RMTI
$27M
| $171K | ﹤0.01% |
196
+95
| +94% | +$77.8K |
|
4445
PUT
Signet Jewelers
SIG
$3.67B
| $171K | ﹤0.01% |
2,700
-2,700
| -50% | -$166K |
|
4446
Valvoline
VVV
$4.3B
| $171K | ﹤0.01% |
7,186
-130,674
| -95% | -$3.03M |
|
|
ISEE
4447
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $171K | ﹤0.01% |
66,282
+53,219
| +407% | +$145K |
|
|
RRD
4448
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
| $171K | ﹤0.01% |
13,600
-5,800
| -30% | -$71.3K |
|
4449
EPAM Systems
EPAM
$5.02B
| $170K | ﹤0.01% |
2,019
-823
| -29% | -$66.2K |
|
|
HEPA
4450
DELISTED
Hepion Pharmaceuticals
HEPA
| $170K | ﹤0.01% |
+1
| New | +$497K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.